Attached files
| file | filename |
|---|---|
| EX-10.18 - EX-10.18 - Phio Pharmaceuticals Corp. | d442134dex1018.htm |
| EX-5.1 - EX-5.1 - Phio Pharmaceuticals Corp. | d442134dex51.htm |
| S-1 - S-1 - Phio Pharmaceuticals Corp. | d442134ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
RXi Pharmaceuticals Corporation
Marlborough, Massachusetts
We hereby consent to the use of our report dated March 30, 2017, relating to the financial statements of RXi Pharmaceuticals Corporation, which is incorporated by reference in this Registration Statement.
We also consent to the reference to us under the caption “Experts” in such Registration Statement.
/s/ BDO USA, LLP
Boston, MA
August 18, 2017